2018
DOI: 10.1590/s2175-97902018000417222
|View full text |Cite
|
Sign up to set email alerts
|

Formulation development and evaluation of colon targeted delayed release methotrexate pellets for the treatment of colonic carcinoma

Abstract: Colonic carcinoma is one of the most common internal malignancies and is the second leading cause of deaths in United States. Methotrexate (MTX) is a drug of choice in the treatment of colon cancer. The aim of the present research work was to develop and characterize colon targeted pellets of MTX for treatment of colonic carcinoma. The product and process parameters were optimized by screening methods. Pellets were prepared by extrusion spheronization using microcrystalline cellulose (MCC) as spheronizing aid … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 10 publications
0
7
0
Order By: Relevance
“…Colorectal cancer is the 2nd most common reason of death from cancer [1]. The conventional chemotherapy is not much fruitful in its treatment as absorption of drug usually occurs in the stomach and intestine after its solubilization [2][3][4]. Nowadays, there is an increased interest in herbal drugs and remedies for the treatment of chronic diseases, including cancer [5].…”
Section: Introductionmentioning
confidence: 99%
“…Colorectal cancer is the 2nd most common reason of death from cancer [1]. The conventional chemotherapy is not much fruitful in its treatment as absorption of drug usually occurs in the stomach and intestine after its solubilization [2][3][4]. Nowadays, there is an increased interest in herbal drugs and remedies for the treatment of chronic diseases, including cancer [5].…”
Section: Introductionmentioning
confidence: 99%
“…4) suggested that as the concentrations of polymer ratio increased up to certain extent, it led to decrease in the % drug release rate at 6 h. The increase in concentration of crosslinking agent up to certain extent also leads to a decrease in % drug release rate at 6 h. It can be concluded that the polymeric ratio (X1) has negative effect on % drug release at 6 h. While concentration of crosslinking agent (X2) also showed negative effect on it. Both the combined effect of concentrations of polymer ratio and crosslinking agent (CaCl 2 ) have also shown a negative impact on % drug release rate at 6 h. However the quadratic responses of both X1 and X2 shown positive response towards % drug release at 6 h [66] . Optimization techniques based on factorial design generated mathematical equations using experimental data and appropriate statistical analysis and helped to select best possible model depending upon independent variables [68] .…”
Section: Able 2: Percent Weight Loss Of 5-fu Sa Fsm Pm Dpm and Bfmentioning
confidence: 92%
“…While concentration of crosslinking agent (X2) did not show much effect on it. Both the combined effect of concentrations of polymer ratio and crosslinking agent leads to positive effect on bead size [66] . The quadratic equation for BS is given as follows, % Q6 (Y3) = (Table 2A).…”
Section: Able 2: Percent Weight Loss Of 5-fu Sa Fsm Pm Dpm and Bfmentioning
confidence: 99%
See 2 more Smart Citations